Company Overview of Nymirum, Inc.
Nymirum, Inc., a drug discovery company, develops drug discovery platforms that target RNA with small molecules. It offers a platform that provides new molecules and scaffolds for newly validated RNA targets, which are fed into the traditional med chem and biology pipeline. The company’s drug discovery platform is an approach that identifies specific atomic-level RNA conformers which co-exist in a dynamic ensemble. Nymirum, Inc. was incorporated in 2009 and is based in Ann Arbor, Michigan.
3510 West Liberty Road
Ann Arbor, MI 48103
Founded in 2009
Key Executives for Nymirum, Inc.
Similar Private Companies By Industry
|Propagenix Inc.||United States|
|Itero Biopharmaceuticals, Inc.||United States|
|GlycoFi, Inc.||United States|
|Biolight Harvesting, Inc.||United States|
|Celeris Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Nymirum, Inc., please visit nymirum.com. Company data is provided by Capital IQ. Please use this form to report any data issues.